Two Seattle-area startups were hand-picked by Bayer for a competitive program to create novel digital health solutions. It’s an endorsement of the region’s growing life science industry and of the… Read More
Prevencio, a Kirkland, Wash., based biotech startup, today announced the results of the first study on its HART test, which predicts coronary artery disease and other potential heart problems. The… Read More
Prevencio, a Kirkland, Wash., based biotech startup, announced today a successful study on its suite of blood diagnostic tests. The study found that Prevencio’s HART CAD diagnosed coronary heart disease… Read More